A Post-Hoc Analysis of the Effect of Smoking Status on COPD Exacerbation Reductions with Budesonide/Glycopyrrolate/Formoterol Fumarate in Patients with COPD in the ETHOS Study

被引:0
作者
Bafadhel, M. [1 ]
Han, M. K. [2 ]
Singh, D. [3 ]
Jenkins, M. [4 ]
Dorinsky, P. [5 ]
Patel, M. [4 ]
机构
[1] Univ Oxford, Nuffield Dept Med, Resp Med Unit, Oxford, England
[2] Univ Michigan, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA
[3] Univ Manchester, Manchester Univ NHS Fdn Trust, Med Evaluat Unit, Manchester, Lancs, England
[4] AstraZeneca, Cambridge, England
[5] AstraZeneca, Durham, NC USA
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A1451
引用
收藏
页数:2
相关论文
共 50 条
[31]   HEALTH CARE RESOURCE USE AND COSTS ASSOCIATED WITH PROMPT INITIATION OF BUDESONIDE/GLYCOPYRROLATE/FORMOTEROL FUMARATE AMONG PATIENTS WITH COPD: THE EROS STUDY [J].
Pollack, Michael ;
Tkacz, Joseph ;
Schinkel, Jill ;
Lewing, Benjamin ;
Agatep, Barnabie ;
Swisher, Sean ;
Patel, Sushma ;
Edwards, Devechio ;
Touchette, Daniel ;
Portillo, Edward C. ;
Feigler, Norbert ;
Strange, Charlie .
CHEST, 2023, 164 (04) :4969A-4970A
[32]   Effect of formoterol/budesonide combination on arterial blood gases in patients with acute exacerbation of COPD [J].
Cazzola, M ;
Noschese, P ;
De Michele, F ;
D'Amato, G ;
Matera, MG .
RESPIRATORY MEDICINE, 2006, 100 (02) :212-217
[33]   Real-World Effectiveness of Budesonide/Glycopyrrolate/Formoterol Fumarate on COPD Exacerbation-Related Healthcare Utilization and Costs: Results From the US Arctos Study [J].
Sethi, S. ;
Germack, H. D. ;
Gozalo, L. ;
McMorrow, D. ;
Feigler, N. ;
Spy, A. ;
Hirpara, S. ;
Szymanski, K. ;
Evangelista, C. ;
Tkacz, J. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2025, 211
[34]   Benefits of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) on Symptoms and Quality of Life in Patients with Chronic Obstructive Pulmonary Disease (COPD) in the ETHOS Trial [J].
Martinez, F. J. ;
Rabe, K. F. ;
Ferguson, G. T. ;
Wedzicha, J. A. ;
Trivedi, R. ;
St Rose, E. ;
Ballal, S. ;
Darken, P. ;
Aurivillius, M. ;
Dorinsky, P. ;
Reisner, C. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
[35]   Pulmonary embolism diagnostic strategies in patients with COPD exacerbation: post-hoc analysis of the PEP trial [J].
Mai, Vicky ;
Rambaud, Geoffroy ;
Motreff, Camille ;
Sanchez, Olivier ;
Roy, Pierre-Marie ;
Auffret, Yannick ;
Le Mao, Raphael ;
Gagnadoux, Frederic ;
Paleiron, Nicolas ;
Schmidt, Jeannot ;
Pastre, Jean ;
Nonent, Michel ;
Tromeur, Cecile ;
Salaun, Pierre-Yves ;
Mismetti, Patrick ;
Girard, Philippe ;
Lacut, Karine ;
Lemarie, Catherine ;
Meyer, Guy ;
Leroyer, Christophe ;
Le Gal, Gregoire ;
Bertoletti, Laurent ;
Couturaud, Francis .
EUROPEAN RESPIRATORY JOURNAL, 2023, 62
[36]   Pulmonary embolism diagnostic strategies in patients with COPD exacerbation: Post-hoc analysis of the PEP trial [J].
Rambaud, Geoffroy ;
Mai, Vicky ;
Motreff, Camille ;
Sanchez, Olivier ;
Roy, Pierre-Marie ;
Auffret, Yannick ;
Le Mao, Raphael ;
Gagnadoux, Frederic ;
Paleiron, Nicolas ;
Schmidt, Jeannot ;
Pastre, Jean ;
Nonent, Michel ;
Tromeur, Cecile ;
Salaun, Pierre-Yves ;
Mismetti, Patrick ;
Girard, Philippe ;
Lacut, Karine ;
Lemari, Catherine A. ;
Meyer, Guy ;
Leroyer, Christophe ;
Bertoletti, Laurent ;
Couturaud, Francis ;
PEP Investigators .
THROMBOSIS RESEARCH, 2023, 231 :58-64
[37]   Relationship Between Prior Inhaled Corticosteroid Use and Benefits of Budesonide/Glycopyrrolate/Formoterol Fumarate on Exacerbation Risk in Patients with Chronic Obstructive Pulmonary Disease: Analysis from the ETHOS Study [J].
Singh, D. ;
Rabe, K. F. ;
Martinez, F. J. ;
Jenkins, M. ;
Patel, M. ;
Dorinsky, P. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
[38]   Benefits of Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (GFF MDI) in Symptomatic Patients with COPD: A Post-Hoc Analysis from a Phase III, Randomized, Placebo-Controlled Study (PINNACLE-4) [J].
Lipworth, B. J. ;
Collier, D. J. ;
Feldman, G. J. ;
Arora, S. ;
Jenkins, M. ;
Reisner, C. ;
Martin, U. J. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
[39]   Bone and ocular safety of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler in COPD: a 52-week randomized study [J].
Kerwin, Edward M. ;
Ferguson, Gary T. ;
Mo, Mindy ;
DeAngelis, Kiernan ;
Dorinsky, Paul .
RESPIRATORY RESEARCH, 2019, 20 (1)
[40]   Modelling peripheral blood eosinophils to identify response to budesonide in COPD: a post-hoc analysis [J].
Bafadhel, Mona ;
Peterson, Stefan ;
De Blas, Miguel ;
Calverley, Peter ;
Rennard, Stephen ;
Richter, Kai ;
Fageras, Malin .
EUROPEAN RESPIRATORY JOURNAL, 2017, 50